Denali shares jump on FDA approval of Hunter syndrome drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. MSFT

Go back to Denali shares jump on FDA approval of Hunter syndrome drug
(NASDAQ: DNLI) Delayed: 24.04 +0.73 (3.13%)
Previous Close $23.31    52 Week High $ 
Open $23.90    52 Week Low $ 
Day High $24.34    P/E N/A 
Day Low $23.65    EPS $ 
Volume 1,248,632